Exercise Testing in Patients with Asymptomatic Moderate Or Severe Aortic Stenosis

Total Page:16

File Type:pdf, Size:1020Kb

Exercise Testing in Patients with Asymptomatic Moderate Or Severe Aortic Stenosis Heart Online First, published on April 13, 2018 as 10.1136/heartjnl-2018-312939 Valvular heart disease ORIGINAL RESEARCH ARTICLE Heart: first published as 10.1136/heartjnl-2018-312939 on 13 April 2018. Downloaded from Exercise testing in patients with asymptomatic moderate or severe aortic stenosis Sahrai Saeed,1,2 Ronak Rajani,1 Reinhard Seifert,2 Denise Parkin,1 John Boyd Chambers1 1Cardiothoracic Centre, Guy’s & ABSTRact there have been some residual concerns about St Thomas’ Hospital, London, UK 2 Objective To assess the safety and tolerability of safety and tolerability. This may partly explain why Department of Heart Disease, ETT was performed in only 5.7% of patients in Haukeland University Hospital, treadmill exercise testing and the association of revealed Bergen, Norway symptoms with outcome in apparently asymptomatic the EuroHeart survey with severe AS in whom it patients with moderate to severe aortic stenosis (AS). was indicated.6 In fact, little data on the safety and Correspondence to Methods A retrospective cohort study of 316 patients tolerability of exercise testing in large populations Dr Sahrai Saeed, Department (age 65±12 years, 67% men) with moderate and severe of moderate to severe asymptomatic AS exist. Thus, of Heart Disease, Haukeland AS who underwent echocardiography and modified our aim was to assess: (1) the safety and tolerability University Hospital, Bergen of ETT; (2) the association of revealed symptoms 5021, Norway; sahrai. saeed@ Bruce exercise treadmill tests (ETTs) at a specialist helse- bergen. no valve clinic. The outcome measures were aortic valve with outcome; and (3) the prognostic significance replacement (AVR), all-cause mortality or a composite of of serial ETT in apparently asymptomatic moderate Received 2 January 2018 AVR and all-cause mortality. or severe AS patients. Revised 22 March 2018 Results At baseline, there were 210 (66%) patients Accepted 23 March 2018 with moderate and 106 (34%) with severe AS. There were 264 (83%) events. 234 (74%) patients reached an METHODS indication for AVR, 145 (69%) with moderate and 88 Patient population (83%) with severe AS (p<0.05). Of the 30 (9%) deaths Between January 2000 and May 2017, a total of recoded during follow-up, 20 (67%) were cardiovascular 651 patients aged >18 years with moderate (effec- 2 related. In total, 797 exercise tests (mean 2.5±2.1 per tive orifice area (EOA) 1.0–1.5 cm ) or severe 2 3 4 patient) were performed. No serious adverse events (EOA <1.0 cm ) AS were assessed in dedicated were observed. The prevalence of revealed symptoms heart valve clinic at Guy’s and St Thomas’ Hospital. at baseline ETT was 29% (n=91) and was significantly During a median follow-up of 25 months (mean higher in severe AS compared with moderate AS 34.9±35.1 months), only seven patients were lost http://heart.bmj.com/ (38%vs23%, p=0.008). Symptoms were revealed in to follow-up. Patients were excluded from the 18%–59% of patients during serial ETT conducted study if they declared spontaneous symptoms justi- over a follow-up period of 34.9 (SD 35.1) months. The fying surgery on the history (n=283), had more event-free survival at 24 months with revealed symptoms than moderate coexistent additional valve disease was 46%±4% and without revealed symptoms was (12 patients with severe mitral regurgitation, 4 70%±4%. with severe mitral stenosis and 5 with severe aortic Conclusions ETT in patients with moderate or severe regurgitation) or had an inability to exercise owing AS is safe and tolerable. Serial exercise testing is useful to concomitant comorbidities such as peripheral on September 27, 2021 by guest. Protected copyright. to reveal symptoms not volunteered on the history and vascular disease (n=2), chronic obstructive pulmo- adds incremental prognostic information to baseline nary disease (n=24), anaemia (n=2) immobility or testing. severe arthritis (n=3). The remaining 316 patients (49%) were apparently asymptomatic by history and eligible for inclusion in the present EXercise Testing in AS (EXTAS) study, a retrospective anal- INTRODUCTION ysis of prospectively collected data. These patients Limiting symptoms are revealed in a significant underwent echocardiography and ETT at presen- proportion of patients with apparently asymp- tation, and then most were restudied when their tomatic aortic stenosis (AS) on treadmill exercise AS crossed the threshold between moderate and testing1 2 and are a class I indication for aortic valve severe and thereafter annually. However, 70 (22%) replacement (AVR) according to both American patients with severe AS and risk factors associated and European guidelines.3 4 Conversely, the absence with higher progression rate were assessed every of symptoms on exercise has an excellent negative 6 months.7 predictive value with an approximately 10% rela- Baseline height, weight and seated blood pressure tive risk of developing spontaneous symptoms or were obtained. Hypercholesterolaemia was defined a clinical event within 12 months.5 Furthermore, as treatment with lipid-lowering therapy. Hyperten- To cite: Saeed S, Rajani R, serial testing may add incremental prognostic infor- sion was defined as previously known hypertension, Seifert R, et al. Heart Epub ahead of print: mation to one performed at baseline. In the litera- past or current treatment with antihypertensive [please include Day Month ture, however, no previous study has reported the agents or blood pressure at the baseline clinic visits Year]. doi:10.1136/ results of serial exercise treadmill tests (ETTs) in >140/90 mm Hg.8 All patients with spontaneous heartjnl-2018-312939 patients with moderate or severe AS. Traditionally, or revealed symptoms underwent conventional Saeed S, et al. Heart 2018;0:1–7. doi:10.1136/heartjnl-2018-312939 1 Copyright Article author (or their employer) 2018. Produced by BMJ Publishing Group Ltd (& BCS) under licence. Valvular heart disease coronary angiography prior to surgical or transcutaneous AVR. (LV) wall thicknesses, chamber dimensions, stroke volume and Coronary artery disease was defined as previous myocardial ejection fraction were measured following the joint European Heart: first published as 10.1136/heartjnl-2018-312939 on 13 April 2018. Downloaded from infarction, coronary artery bypass grafting or percutaneous Association of Cardiovascular Imaging and American Society coronary intervention, or angiographic evidence of coronary of Cardiology guidelines.3 4 14 LV hypertrophy was diagnosed artery disease. Most patients were studied prospectively in according to the prognostically validated cut-off values of LV previously reported studies,1 9 10 but the aims and analyses were mass >46.7 g/m2.7 in women and 49.2 g/m2.7 in men, respec- different from this larger analysis. Approval for the study was tively, and relative wall thickness as LV posterior wall thickness/ obtained by local institutional review board (study protocol n. LV internal radius at end-diastole, and considered increased 7461/2017). The study was managed and conducted in accor- if ≥0.430.15 EOA was calculated using the continuity equation dance with the Declaration of Helsinki and latest Good Clinical employing the ratio of subaortic to transaortic systolic velocity Practice guidelines. integral. Exercise testing Study endpoints All ETTs were performed according to American College of Endpoints recorded during follow-up were AVR (either surgical Cardiology/American Heart Association practice guidelines or via a transcatheter approach), all-cause mortality or a using a Bruce protocol modified by two warm-up stages.11 12 composite of AVR and all-cause mortality. Deaths were classified ETT was only done if the patient was asymptomatic on symptom as cardiovascular or non-cardiac and confirmed by reviewing the inquiry. The test was conducted by an exercise physiologist and electronic patient record or a death certificate with censoring either a cardiologist or cardiac nurse. During the test, subjects date 19 September 2017. Follow-up time was calculated from were questioned for symptoms every 2 min, and the haemo- the baseline ETT until AVR, death or censoring. dynamic parameters and a 12-lead ECG are recorded at base- line, at the end of each stage and at peak exercise. The test was Statistical analyses stopped prematurely for symptoms (significant breathlessness SPSS V.24.0 was used for data management and statistical anal- or any chest constriction or dizziness), progressive ventricular yses. Continuous variables were tested for normality of distri- ectopy >3 beats, new atrial fibrillation, a sustained fall in systolic bution and presented as mean±SD, and categorical variables blood pressure >20 mm Hg from the previous stage or more as percentages. Intergroup comparison was performed using than 5 mm ST segment depression. Significant breathlessness Student’s t test or χ2 test, as appropriate. Random slope/inter- was differentiated clinically from physiological breathlessness cept linear mixed effects models with first-order autoregression by the presence of distress, the inability to speak, facial pallor were used to estimate trends in continuous variables of ETT visits and sometimes associated ventricular ectopy or a fall in blood over time. Categorical variables were test with McNemar’s test. pressure. The following were recorded: reason(s) for stopping Survival curves were generated using Kaplan-Meier methods (symptom, fall in blood pressure, ventricular ectopy, ST segment for the endpoints of interest, and groups were compared using depression
Recommended publications
  • Modified Bruce Protocol Mets
    Modified Bruce Protocol Mets entwining,Yttric and ropyhis decoupling Wilson cybernate mundifies almost imponed bleakly, onside. though Elwin Glynn pull-ups wites shamelessly.his artifices append. Squamulose Warden This suggests hibernating myocardium of fixed defects in modified protocol holds degrees of revascularization and lung function in asymptomatic patients ensuring privacy of cardiac output Gibbons RJ, Balady GJ, Beasley JW, et al. Cardiovascular Disease Risk Factors There are several factors that increase the risk for having CVD. If st segment: no other protocols present study based on protocol? We may share certain information about our users with our advertising and analytics partners. Bruce treadmill protocol mets vo2 Jottit. Unscrambling the anchor of METs Los Angeles Times. Ultimate Herpes Modified Bruce Protocol Mets Calculator. Pain in critically ill patients. Overall, fare with CMR is limited. In contrast, Myers et al. The test is your muscles use, children and the end of three categories. Infection Control Procedures Adhere to relevant Hospital and Health Service infection control protocols or procedures at all times and in all facets of EST. Prognostic Value of Functional Capacity for Different X-MOL. The bruce protocol remains as a given the american college of exercise stress testing may be instructed not drink caffeinated beverages can probably come up and age. Aerobic Fitness Testing iWorx. Abrupt disappearance of the delta wave is presumptive evidence of a longer anterograde effective refractory period of the accessory pathway. Degree of depression severity. What via the difference between Bruce protocol and modified Bruce protocol? Maximum Treadmill Cardiovascular Test ExRxnet. MODIFIED BRUCE are maximal protocol as they Employing these protocols under.
    [Show full text]
  • Exercise Stress Test
    Exercise Stress Test If test results are negative, then later after OVERVIEW discharge: symptom-limited at 3-6 weeks. The purpose of this document is to b. Soon after discharge: symptom-limited at 14-21 specifically identify the critical components days. involved in performing an exercise stress test. 3) Risk stratification of patients with chronic stable CAD This information serves as a standard for into a low-risk category that can be managed medical- all nuclear cardiology laboratories. ly or a high-risk category that should be considered for coronary revascularization. This document will cover indications, 4) Risk stratification of low-risk acute coronary syn- contraindications, limitations, testing drome patients (without active ischemia and/or heart procedure, and indications for early failure) 6-12 hours after presentation or intermediate- termination of exercise. risk acute coronary syndrome patients 1 to 3 days after presentation. 5) Risk stratification before noncardiac surgery in EXERCISE STRESS TEST patients with known CAD, diabetes mellitus, Exercise is the preferred stress modality in patients who peripheral or cerebrovascular disease. are able to achieve at least 85% of age-adjusted maximal 6) To evaluate the efficacy of therapeutic interventions predicted heart rate (MPHR) and five metabolic equivalents. (anti-ischemic drug therapy or coronary revasculariza- tion) and in tracking subsequent risk based on serial Exercise stress testing is a powerful risk stratification tool changes in myocardial perfusion in patients with and is useful in assessing the efficacy of anti-ischemic drug known CAD. therapy and/or coronary revascularization. CONTRAINDICATIONS The treadmill is the most widely used stress modality. The Contraindications are considered absolute or relative.
    [Show full text]
  • American Society of Echocardiography Recommendations for Performance, Interpretation, and Application of Stress Echocardiography
    GUIDELINES AND STANDARDS American Society of Echocardiography Recommendations for Performance, Interpretation, and Application of Stress Echocardiography Patricia A. Pellikka, MD, Sherif F. Nagueh, MD, Abdou A. Elhendy, MD, PhD, Cathryn A. Kuehl, RDCS, and Stephen G. Sawada, MD, Rochester, Minnesota; Houston, Texas; Marshfield, Wisconsin; and Indianapolis, Indiana dvances since the 1998 publication of the TABLE OF CONTENTS A Recommendations for Performance and Interpreta- tion of Stress Echocardiography1 include improve- Methodology....................................................1021 ments in imaging equipment, refinements in stress Imaging Equipment and Technique............1021 testing protocols and standards for image interpre- Stress Testing Methods...... ............................1022 tation, and important progress toward quantitative Training Requirements and Maintenance analysis. Moreover, the roles of stress echocardiog- of Competency...... .....................................1023 raphy for cardiac risk stratification and for assess- Image Interpretation......................................1024 ment of myocardial viability are now well docu- Table 1. Normal and Ischemic mented. Specific recommendations and main points Responses for Various Modalities are identified in bold. of Stress........................................................1025 Quantitative Analysis Methods.....................1025 Accuracy...... .....................................................1026 False-negative Studies...... ..............................1026
    [Show full text]
  • “Cardiac Solution” Program Tip Sheet
    “Cardiac Solution” Program Tip Sheet MYOCARDIAL PERFUSION IMAGING (MPI) vs. STRESS ECHOCARDIOGRAPHY (SE) Main Points about the Two Tests: Both tests have equal diagnostic accuracy for coronary artery disease, with MPI showing greater sensitivity and SE showing greater specificity. MPI is based upon the expectation of relatively reduced blood flow in a myocardial segment during exercise or pharmacologic coronary microvessel dilation, while SE is based upon development of wall motion abnormality provoked by myocardial ischemia during treadmill exercise or similar stress. In order to perform a SE, one would prefer to have a patient who could perform treadmill exercise well, along with a good acoustic imaging window, while MPI can be performed with either exercise or the pharmacologic option. Exercise can also provide the additional information from the EKG, when the baseline EKG does not already have substantial abnormality (e.g. a 1 mm ST segment depression at baseline, left bundle branch block, ventricular pacing, PVCs, or pre-excitation). Even with MPI, an exercise modality is preferred over pharmacologic vasodilation due to the additional functional and EKG information inherent in exercise testing. However, in some patients, such as those with a pre-existing wall motion abnormality, left bundle branch block, ventricular paced rhythms, frequent PVCs, or pre-excitation (WPW), the related cardiac contraction pattern during exercise could obscure the effects of ischemia, making a pharmacologic approach more helpful. The radiation exposure of SE is zero, while MPI incurs a radiation Radiation Exposure dose of 7-24 mSv (the equivalent of about 117-400 PA & lateral chest X-rays), with an increase in lifetime radiation exposure and its MPI: 7 - 24 mSv associated cancer risk.
    [Show full text]
  • Cardiovascular and Surgical Outcomes | 2016
    Cardiovascular and Surgical Outcomes | 2016 BayCareHeart.org Clinical Review Committee Dear Colleague, Augustine E. Agocha, MD, PhD Table of Contents We’re pleased to provide this summary of key 2016 cardiovascular national benchmarking along with patient-centered care, assures St. Joseph’s Hospital program highlights. BayCare’s cardiovascular programs are dedicated the best treatment for each patient. In addition to our volume and Mahesh Amin, MD New in 2016 ....................................................... 3 Morton Plant Hospital to providing the highest quality care and services throughout Florida outcomes data, we’re excited to highlight some of our world-class and beyond. Our advanced facilities permit us to care for complex programs including our fast-growing arrhythmia, structural heart Rodrigo Bolaños, MD Why Choose Us? ............................................... 5 Winter Haven Hospital cardiac disease with programs specializing in coronary artery disease, and percutaneous coronary intervention programs. As a system of Cardiovascular Surgery .................................... 7 George Dagher, MD heart failure, structural heart and valve disease, peripheral vascular community hospitals within West Central Florida, we’re committed to Morton Plant North Bay Hospital disease, arrhythmia, pediatric and congenital heart disease and being a leader in providing superior heart care. Advanced Structural Heart and Valve .........13 diseases of the aorta. David Evans, MD We hope you can utilize the information in this outcomes book to help Winter Haven Hospital Arrhythmia ......................................................17 BayCare off ers comprehensive forums for physicians, staff and with patient care and treatment decisions. For more information or to David W. Kohl, MD administrators to share clinical expertise, outcomes data, research and refer a patient to any of our programs, call (844) 344-1990.
    [Show full text]
  • Stress Echocardiography in Ischemic Heart Disease: from the American Society of Echocardiography
    GUIDELINES AND STANDARDS Guidelines for Performance, Interpretation, and Application of Stress Echocardiography in Ischemic Heart Disease: From the American Society of Echocardiography Patricia A. Pellikka, MD, FASE, Chair, Adelaide Arruda-Olson, MD, PhD, FASE, Farooq A. Chaudhry, MD, FASE,* Ming Hui Chen, MD, MMSc, FASE, Jane E. Marshall, RDCS, FASE, Thomas R. Porter, MD, FASE, and Stephen G. Sawada, MD, Rochester, Minnesota; New York, New York; Boston, Massachusetts; Omaha, Nebraska; Indianapolis, Indiana Keywords: Echocardiography, Stress, Guidelines, Imaging, Ischemic heart disease, Stress test, Pediatrics This document is endorsed by the following ASE International Alliance Partners: Argentine Federation of Cardiology, Argentine Society of Cardiology, ASEAN Society of Echocardiography, Association of Echocardiography and Cardiovascular Imaging of the Interamerican Society of Cardiology, Australasian Sonographers Association, Canadian Society of Echocardiography, Chinese Society of Echocardiography, Cuban Society of Cardiography Echocardiography Section, Department of Cardiovascular Imaging of the Brazilian Society of Cardiology, Indian Academy of Echocardiography, Indian Association of Cardiovascular Thoracic Anaesthesiologists, Indonesian Society of Echocardiography, Iranian Society of Echocardiography, Israeli Working Group on Echocardiography, Italian Association of CardioThoracic and Vascular Anaesthesia and Intensive Care, Japanese Society of Echocardiography, Korean Society of Echocardiography, Mexican Society of Echocardiography
    [Show full text]
  • Stress, Protocols, and Tracers
    ASNC IMAGING GUIDELINES ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers a b c Milena J. Henzlova, MD, W. Lane Duvall, MD, Andrew J. Einstein, MD, d e Mark I. Travin, MD, and Hein J. Verberne, MD a Mount Sinai Medical Center, New York, NY b Hartford Hospital, Hartford, CT c New York Presbyterian Hospital, Columbia University Medical Center, New York, NY d Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY e Academic Medical Center, Amsterdam, The Netherlands doi:10.1007/s12350-015-0387-x Abbreviations LEHR Low energy high resolution A2A Adenosine 2a LVEF Left ventricular ejection fraction AHA American Heart Association MBq Megabecquerels ALARA As low as reasonably achievable mCi Millicuries AV Atrioventricular MPI Myocardial perfusion imaging BP Blood pressure MRI Magnetic resonance imaging CBF Coronary blood flow mSv Millisievert CAD Coronary artery disease NE Norepinephrine CPET Cardiopulmonary exercise testing NET1 Norepinephrine transporter-1 DSP Deconvolution of septal penetration NPO Nil per os (nothing by mouth) ECG Electrocardiogram NYHA New York Heart Association EF Ejection fraction PET Positron emission tomography ESRD End-stage renal disease ROI Region of interest HF Heart failure SPECT Single-photon emission computed HFrEF Heart failure (with) reduced ejection tomography fraction TAVR Transcatheter aortic valve replacement HMR Heart-to-mediastinum ratio WR Washout rate ICD Implantable cardioversion defibrillator WPW Wolff-Parkinson White IV Intravenous
    [Show full text]
  • American College of Chest Physicians
    American Thoracic Society/ American College of Chest Physicians ATS/ACCP Statement on Cardiopulmonary Exercise Testing This Joint Statement of the American Thoracic Society (ATS) and the American College of Chest Physicians (ACCP) was adopted by the ATS Board of Directors,March 1, 2002 and by the ACCP Health Science Policy Committee, November 1, 2001 CONTENTS 3.2 Maximal Incremental Treadmill Protocols 3.3 Constant Work Rate Protocol Executive Summary 4. Conducting the Test . .......................226 I. Introduction 4.1 Preliminary Requirements for Exercise Testing Idelle M. Weisman 4.2 Day of the Test Purpose and Scope ............................212 4.3 Patient Safety 5. Personnel Qualifications . ..................227 II. Indications for Cardiopulmonary Exercise Testing Idelle M. Weisman, Darcy Marciniuk, Fernando J. Martinez, IV. Conceptual and Physiologic Basis of Cardiopulmonary Frank Sciurba, Darryl Sue, Jonathan Myers Exercise Testing Measurements 1. Evaluation of Exercise Intolerance ..............214 Bruce Johnson, Brian Whipp, Jorge Zeballos, Idelle M. Weisman, 2. Unexplained Dyspnea ........................215 Ken Beck, Donald Mahler, John Cotes, Kathy Sietsema, 3. Evaluation of Patients with Cardiovascular Disease. 215 Kieran Killian 4. Evaluation of Patients with Respiratory Disease . 216 1. Oxygen Uptake . .............228 4.1 Chronic Obstructive Pulmonary Disease (COPD) 1.1 V˙ o2 Work Rate Relationship 4.2 Interstitial Lung Disease (ILD) 1.2 V˙ o2 max–V˙ o2 peak 4.3 Chronic Pulmonary Vascular Disease (PVD) 2. CO2 Output . .....229 4.4 Cystic Fibrosis 3. Respiratory Exchange Ratio . ......230 4.5 Exercise Induced Broncospasm (EIB) 4. Anaerobic Threshold . .....230 5. Preoperative Evaluation ......................216 4.1Clinical Applications of the Anaerobic Threshold 5.1 Preoperative Evaluation for Lung Cancer Resectional 4.2 Determination of the Anaerobic Threshold Surgery 4.3 Noninvasive Determinations 5.2 Lung Volume Reduction Surgery (LVRS) 5.
    [Show full text]
  • Practice Guidelines for the Diagnosis and Management of Systolic Heart Failure in Low- and Middle-Income Countries Ragavendra R
    j WHITE PAPER gRECS Practice Guidelines for the Diagnosis and Management of Systolic Heart Failure in Low- and Middle-Income Countries Ragavendra R. Baliga*, G. William Decy, Jagat Narulaz Columbus, OH, USA; Boston, MA, USA; and New York, NY, USA TABLE OF CONTENTS Conclusions ..................................................166 Clinical assessment..........................................141 References ....................................................166 Symptoms of HF and relevant facets in history ... 141 Heart failure (HF) occurs when the cardiac output is Physical examination ..................................144 not adequate to meet the metabolic demands of the tissues or is able to do so only at an elevated ventricular filling Diagnostic tests ..............................................150 pressure. Laboratory...............................................150 BNP and amino-terminal proBNP ...................150 ECG......................................................150 CLINICAL ASSESSMENT Chest x-ray ..............................................152 Echocardiography and Doppler ......................152 Symptoms of HF and relevant facets in history Stress testing ............................................153 Compiling the history of a patient with heart failure should Six-minute walk test, cardiopulmonary stress test/ focus on establishing the diagnosis; determining the regular stress test .....................................154 etiology; evaluating functional status including shortness of fl Right heart catheterization
    [Show full text]
  • Constriction Vs Restriction
    Pericardial Diseases Constriction vs Restriction Jae K. Oh, MD ASE Board Review 2017 ©2012 MFMER | 3200268v3(2010)-1 Echo Evaluation of Pericardial Diseases • Constriction vs Restriction • Typical Constriction • Effusive CP • Transient CP • CP and Tricuspid Regurgitation • Multi-modality Imaging • Cases • Tamponade ©2016 MFMER | slide-2 Restriction vs Constriction Paradoxical DHF or HFpEF No paradoxical Pulse Paradoxical No variation Diastolic Filling Variation Decreased Relaxation (e’) Paradoxical Inspiration HV reversal Expiration Concordant LV/RV SP Discordant Diagnosis should be based on their characteristic HEMODYNAMICS CP983059-3 ©2016 MFMER©2011 | slide-3 MFME R | slide-3 Mayo Echo Diagnostic Criteria Septal motion abnormality MV Flow Velocity Medial e’ ≥ 8 cm/s Restrictive (E/A >1) Hepatic Vein Diastolic reversal with expiration Sensitivity 87 % Specificity 91 % Welch et al Circ Imaging 2014 ©2016 MFMER | slide-4 Hemodynamics of Myocardial Disease Concordant change in PCWP and LVDP 80 LV 40 PCW Inspiration Expiration Inspiration 0 Hatle et al. Circ 1989 ©2011 CP1105201MFMER-1 | slide-5 ©2016 MFMER | slide-5 Constrictive Pericarditis E E Mitral Inflow vs Cath 1.Dissociation between intrathoracic and intracardiac pressures 2.Interventricular Dependence CP992397-39 ©2016 MFMER | slide-6 Hemodynamics in Constriction Intracardiac pressure Δ < intrathoracic pressure Δ Interventricular dependence CP1051850-19 ©2016 MFMER | slide-7 Constriction Abnormal septal motion Interventricular Dependence “Consider constriction if there is septal
    [Show full text]
  • Guidelines for Performance, Interpretation, and Application of Stress Echocardiography in Ischemic Heart Disease: from the American Society of Echocardiography
    GUIDELINES AND STANDARDS Guidelines for Performance, Interpretation, and Application of Stress Echocardiography in Ischemic Heart Disease: From the American Society of Echocardiography Patricia A. Pellikka, MD, FASE, Chair, Adelaide Arruda-Olson, MD, PhD, FASE, Farooq A. Chaudhry, MD, FASE,* Ming Hui Chen, MD, MMSc, FASE, Jane E. Marshall, RDCS, FASE, Thomas R. Porter, MD, FASE, and Stephen G. Sawada, MD, Rochester, Minnesota; New York, New York; Boston, Massachusetts; Omaha, Nebraska; Indianapolis, Indiana Keywords: Echocardiography, Stress, Guidelines, Imaging, Ischemic heart disease, Stress test, Pediatrics This document is endorsed by the following ASE International Alliance Partners: Argentine Federation of Cardiology, Argentine Society of Cardiology, ASEAN Society of Echocardiography, Association of Echocardiography and Cardiovascular Imaging of the Interamerican Society of Cardiology, Australasian Sonographers Association, Canadian Society of Echocardiography, Chinese Society of Echocardiography, Cuban Society of Cardiography Echocardiography Section, Department of Cardiovascular Imaging of the Brazilian Society of Cardiology, Indian Academy of Echocardiography, Indian Association of Cardiovascular Thoracic Anaesthesiologists, Indonesian Society of Echocardiography, Iranian Society of Echocardiography, Israeli Working Group on Echocardiography, Italian Association of CardioThoracic and Vascular Anaesthesia and Intensive Care, Japanese Society of Echocardiography, Korean Society of Echocardiography, Mexican Society of Echocardiography
    [Show full text]
  • Death During Exercise Testing in a Patient with Asymptomatic Severe Aortic Stenosis
    Edorium J Cardiol 2018;4:100009C03MS2018. Shah et al. 1 www.edoriumjournalofcardiology.com CASEORIGINAL REPORT ARTICLE PEER REVIEWED |OPEN OPEN ACCESS ACCESS Death during exercise testing in a patient with asymptomatic severe aortic stenosis Mahek Shah, Anuraj Sudhakaran, Baburaj Aparna, Muhammad Qasim, Brijesh Patel, Lohit Garg, Bruce Feldman ABSTRACT hemodynamic instability leading to death. A comprehensive registry of safety data is needed. Introduction: Patients with symptomatic severe Clinical vigilance and physician supervision aortic valve stenosis (AS) experience short during stress testing may minimize the risk of and long-term survival benefit with aortic serious adverse events. valve replacement (AVR). Among patients with asymptomatic severe AS (ASAS) current Keywords: Asymptomatic severe aortic stenosis, guidelines recommend exercise stress testing Exercise treadmill testing, Mortality, Safety (ETT) as a safe and effective method to risk stratify patients and to assist with the timing How to cite this article of AVR. We discuss the course of disease in AS, review the role of ETT and express concerns Shah M, Sudhakaran A, Aparna B, Qasim M, Patel B, about the safety of performing stress tests in Garg L, Feldman B. Death during exercise testing in asymptomatic patients with severe AS. Case a patient with asymptomatic severe aortic stenosis. Report: We describe the case of a 69-year-old Edorium J Cardiol 2018;4:100009C03MS2018. male with left bundle branch block and ASAS who underwent ETT with echocardiographic imaging. We describe the details of the patient’s Article ID: 100009C03MS2018 clinical, ECG and echo doppler parameters prior, during and following the test. Patient developed pulseless electrical activity during ********* early recovery with eventual resuscitation and mechanical support.
    [Show full text]